Seres Therapeutics Inc
Closed
SectorHealthcare
5.64 -1.23
Overview
Share price change
24h
Min
5.54
Max
5.66
Income | 24M 4.6M |
|---|---|
Sales | 378K 736K |
P/E Sector Avg | 11.652 56.659 |
EPS | -1.5 |
Profit margin | 622.418 |
Employees | 66 |
EBITDA | -2.1M -21M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +197.2% upside |
Next Earnings | 4 Nov 2026 |
|---|
Market Cap | 610K 49M |
|---|---|
Previous open | 6.87 |
Previous close | 5.64 |
News Sentiment
By Acuity
75%
25%
305 / 339 Healthcare
Seres Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Seres Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 17 USD 197.2%
High 22 USD
Low 12 USD
Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$